COMPOUDING OF CUSTOMIZED PARENTERAL NURTITION
ID: 36C24925Q0120Type: Sources Sought
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF249-NETWORK CONTRACT OFFICE 9 (36C249)MURFREESBORO, TN, 37129, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

MEDICAL- PHARMACOLOGY (Q517)

Original Source

https://sam.gov/opp/e7636d9d3e744315bf00b5b3a27e078e/view
Timeline
    Description

    The Department of Veterans Affairs, specifically the Memphis VA Medical Center, is seeking to negotiate a Sole Source Award with An I.V., LLC for the compounding of customized parenteral nutrition (PN) products. The procurement aims to provide same-day delivery of patient-specific parenteral nutrition compounds, with orders accepted until 3 PM for delivery by 7 PM, fulfilling an annual requirement of approximately 445 bags over a five-year period from February 2025 to September 2029. This service is critical for patients requiring specialized nutritional support, and the selected vendor must comply with stringent quality assurance standards and federal regulations, including accreditation by the Pharmacy Compounding Accreditation Board. Interested parties must submit their capabilities by 12:00 PM CST on February 6, 2025, to the Contract Specialist, William Blassingame, at william.blassingame@va.gov, as no formal solicitation will be issued.

    Point(s) of Contact
    William BlassingameContract Specialist
    (615) 336-4630
    william.blassingame@va.gov
    Files
    Title
    Posted
    P01 - STATEMENT OF WORK - PARENTERAL NUTRITION COMPOUNDING - MEMPHIS VAMC - W.pdf
    The Lt. Col. Luke Weathers, Jr. VAMC is issuing a Request for Proposal (RFP) for outsourced customized patient-specific parenteral nutrition compounding services with same-day delivery. This initiative aims to fulfill patient needs by ensuring deliveries of parenteral nutrition orders by 7 PM for orders placed by 3 PM, with a total requirement of 445 bags annually over a five-year period from February 2025 to September 2029. The contract mandates vendors to be accredited by the Pharmacy Compounding Accreditation Board and requires comprehensive compliance with applicable federal, state, and JCAHO quality standards. It covers specific tasks such as order transmission, labeling, daily communication, and vendor expectations regarding operational capability and quality assurance. Furthermore, the RFP outlines strict protocols regarding information and data security for contractors, detailing the reporting process for security incidents and the potential for liquidated damages in case of data breaches. Finally, training for contractor personnel on privacy and security measures is required before access to VA information systems is granted, highlighting the VA's commitment to maintaining stringent security and quality standards in patient care services.
    S01 - SOURCES SOUGHT 36C24925Q0120 - PARENTERAL NUTRITION - MEMPHIS VAMC -WB.pdf
    The Memphis VA Medical Center is seeking to negotiate a Sole Source Award with An I.V., LLC for the compounding of customized parenteral nutrition (PN) products. This procurement aligns with FAR regulations indicating that only one source can fulfill the agency's requirements due to the proprietary nature of the Total Parenteral Nutrition system. The vendor must provide same-day delivery services for patient-specific PN compounds, with orders accepted until 3 PM for delivery by 7 PM. The contract is structured as a Base Period from February 17, 2025, to September 30, 2025, followed by four additional ordering periods through 2029. Key tasks for the contractor include maintaining quality assurance standards, complying with federal and state regulations, labeling per USP guidelines, and ensuring timely communication with the VA's pharmacy personnel. The vendor is also expected to handle product recalls and returns efficiently. Interested parties have until noon on February 6, 2025, to submit their capabilities, although a solicitation is not being released. If no responses are received, the contract will move forward exclusively with An I.V., LLC. This document represents a critical component of the VA’s procurement process to ensure adequate care for patients requiring parenteral nutrition.
    Lifecycle
    Title
    Type
    COMPOUDING OF CUSTOMIZED PARENTERAL NURTITION
    Currently viewing
    Sources Sought
    Similar Opportunities
    6505--Bevacizumab Injection
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to procure Bevacizumab Injections through a Request for Proposal (RFP) designated as 36E79725R0019. This procurement aims to secure an uninterrupted supply of Bevacizumab, a critical pharmaceutical product used in the treatment of various medical conditions, for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will span one year with four additional one-year option periods, and the estimated annual requirements include various package sizes of Bevacizumab, with a total estimated usage of over 100,000 vials. Interested offerors must submit their proposals by March 4, 2025, at 2:30 PM Central Time, and can direct inquiries to Contract Specialist Matthew Poulin at Matthew.Poulin@va.gov or by phone at 708-786-5186.
    6505--Mycophenolate Mofetil RFP
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) numbered 36E79725R0010 for the procurement of Mycophenolate Mofetil tablets and capsules, intended for use by the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The procurement aims to secure a reliable source of supply for these essential medications, with a contract term of one year and the option to extend for four additional years, emphasizing the importance of uninterrupted access to critical pharmaceuticals for veterans and associated federal programs. Interested offerors must comply with specific packaging requirements, including child-resistant closures for smaller bottles, and are encouraged to check the designated URL for updates, with the solicitation expected to be issued around February 14, 2025, and offers accepted until February 28, 2025. For inquiries, potential bidders can contact Amber Zavala at amber.zavala@va.gov or by phone at (708) 786-5245.
    6505--Phenytoin SA Capsules (VA-25-00022318)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) for the procurement of Phenytoin Sodium Extended 100MG Sustained Action Capsules, designated as solicitation number 36E79725R0016. This unrestricted contract aims to ensure a reliable supply of these essential medications for the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS), with one contract awarded for an initial period of one year and the option for four additional one-year periods. The estimated annual requirement is approximately 16,653 units, highlighting the critical need for uninterrupted supply to support service members and associated organizations. Interested offerors should submit their proposals by March 7, 2025, following the electronic issuance of the RFP on or about February 21, 2025, and may direct inquiries to Contract Specialist Youlanda Duggar at youlanda.duggar@va.gov.
    Q401--Certified Nursing Assistants
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for Certified Nursing Assistant (CNA) services to support the Lt Col Luke Weathers Jr Veterans Affairs Medical Center in Memphis, TN. The contract, valued at approximately $20.5 million, is set aside for competition among Service-Disabled Veteran-Owned Small Businesses and spans five years, commencing on March 10, 2025. These services are crucial for providing direct patient care, hygiene assistance, and support for veterans’ recovery, reflecting the government's commitment to high-quality healthcare for veterans. Interested contractors must submit their proposals by January 24, 2025, and can contact Contract Specialist Christina Curley at Christina.Curley@va.gov for further information.
    6505--Domestic Pharmaceuticals/Med/Surge
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is conducting a Sources Sought notice to identify qualified domestic pharmaceutical manufacturers capable of supplying a range of medications for the Consolidated Mail Outpatient Pharmacy (CMOP). The procurement aims to ensure a reliable supply of domestically manufactured pharmaceuticals, including glucose test strips, hypertension treatments, and various other essential medications. This initiative is crucial for maintaining the health and well-being of veterans, as it supports ongoing healthcare needs. Interested manufacturers must submit their capability statements by February 5, 2025, to Josie Linaweaver at josie.linaweaver@va.gov, and are reminded to register in the System for Award Management (SAM) prior to contract award.
    6515--Pharmacy Management System ScriptPro Brand name or Equal
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of a ScriptPro Pharmacy Management System or an equivalent solution, as outlined in the combined synopsis/solicitation RFQ 36C26225Q0148. This procurement aims to enhance pharmacy management capabilities across various Veterans Integrated Service Network (VISN) 22 medical facilities and clinics, ensuring high-quality healthcare service delivery through reliable technological advancements. Interested vendors are encouraged to participate, particularly small businesses, including those owned by veterans and women, with bids due by February 4, 2025, at 7:00 AM PST. For inquiries, potential bidders should contact Contracting Officer Anthony Dela Cruz at anthony.delacruz@va.gov or by phone at 562-766-2284.
    6505--Fluticasone Propionate 50 MCG/Spray Soln, Nasal, 16GM
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Fluticasone Propionate 50 MCG/Spray solution, nasal, 16GM, intended for use by various federal agencies including the Department of Defense, Bureau of Prisons, and Indian Health Service. The objective of this procurement is to secure a reliable and uninterrupted supply of this medication for a contract period of one year, with the possibility of four additional one-year extensions. This medication is crucial for treating nasal conditions, and the estimated annual requirement is approximately 5,784,828 bottles. The solicitation will be available electronically on or around February 11, 2025, with a closing date set for February 25, 2025. Interested vendors should direct inquiries to Michael Olszewski at michael.olszewski@va.gov or call 708-786-4966.
    Prescription-fill services
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the VISN 15 Network Contracting Office, is seeking qualified contractors to provide prescription-fill services for eligible veterans at the Harry S. Truman Memorial Veterans’ Hospital (HSTMVH) and its associated community-based outpatient clinics (CBOCs) and Home Based Primary Care (HBPC) program, starting June 1, 2025. The contractor will be responsible for filling and dispensing medications, offering patient counseling, and ensuring compliance with Joint Commission standards while maintaining operations during specified hours. This initiative is crucial for enhancing access to pharmacy services for veterans, thereby prioritizing their health and medication management. Interested parties must submit their responses, including company information and capabilities, to Steve Parrott at stephen.parrott@va.gov by February 7, 2025, at 10:00 AM CST, as this is a Request for Information (RFI) and not a solicitation.
    6505--Rituximab and Biosimilars
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) designated as 36E79725R0021 for the procurement of Rituximab and its biosimilars, aimed at ensuring a reliable supply for various federal entities, including the Department of Defense and the Bureau of Prisons. The contract will span one year with four additional one-year options, emphasizing the necessity of maintaining an uninterrupted supply chain for these critical medications. Offerors must provide the exact product names along with unique National Drug Codes (NDC), with estimated annual requirements of 17,858 vials of Rituximab 10mg/ml and 25,111 vials of the 50mg/ml variant. The solicitation is expected to be published around February 17, 2025, with a closing date around March 4, 2025; interested parties should direct inquiries to Deb Fassl at Deborah.Fassl@va.gov.
    6505--Tamsulosin Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Tamsulosin Hydrochloride capsules as part of its Pharmaceutical Prime Vendor (PPV) Programs. Offerors are required to submit pricing for a base year and four option years, ensuring compliance with FDA standards and providing a unique 11-digit National Drug Code (NDC) for each product. This procurement is vital for maintaining a consistent supply of necessary pharmaceuticals to federal healthcare facilities, adhering to regulatory standards while ensuring availability and pricing stability. Interested parties must submit their offers by February 24, 2025, at 2:30 PM CST, and can contact Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further information.